LIMN Liminatus Pharma, Inc.

Fundamentals / CIK 0001971387 / USD
Other share classes on CIK 0001971387: LIMNW

Liminatus Pharma, Inc. reported $3.40M in total assets and a net loss of $12.52M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LIMN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$9.54MFY 2024 Net Income: -$3.55M2024FY 2025 Net Income: -$10.21M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development -- $2.69M
Total Operating Expenses $2.97M $3.33M
Operating Income -$2.97M -$3.33M
EBITDA -$2.97M --
Interest Income $77K $123K
Interest Expense $216K $339K
Net Income -$10.21M -$3.55M
Basic EPS -$0.43 -$0.20
Diluted EPS -$0.43 -$0.20
Basic Shares Outstanding 23.8M 17.5M
Diluted Shares Outstanding 23.8M 17.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Research & Development $600K $400K -- -- -- -- -- $357K
Total Operating Expenses $1.38M $1.10M $884K $701K $1.12M $264K -- $543K
Operating Income -$1.38M -$1.10M -$884K -$701K -$1.12M -$264K -$167K -$543K
EBITDA -$1.38M -$1.10M -- -- -- -- -- --
Interest Income -- -- $0 $0 $24K $52K -- $34K
Interest Expense $19K $19K $19K $19K $62K $116K -- $93K
Net Income -$1.41M -$1.12M -$8.17M -$1.82M $113K -$328K -$230K -$601K
Basic EPS -$0.03 -$0.03 -- -$0.07 $0.00 -$0.02 -- -$0.03
Diluted EPS -$0.03 -$0.03 -- -$0.07 $0.00 -$0.02 -- -$0.03
Basic Shares Outstanding 48.4M 36.0M -- 27.0M 23.3M 17.5M -- 17.5M
Diluted Shares Outstanding 48.4M 36.0M -- 27.0M 23.3M 17.5M -- 17.5M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $338K $56K
Cash & Short-Term Investments $338K $56K
Total Current Assets $501K $5.28M
Property, Plant & Equipment, Net $12K $941
Total Non-Current Assets $12K $127K
Total Assets $513K $5.41M
Short-Term Debt $1.44M $19.97M
Total Current Liabilities $10.30M $24.75M
Total Non-Current Liabilities $29K $0
Total Liabilities $10.33M $24.75M
Total Debt (incl. Leases) $1.44M $19.97M
Common Stock $2.7K $1.8K
Retained Earnings -$38.87M -$28.67M
Total Stockholders' Equity -$9.81M -$19.34M
Total Equity -$9.81M -$19.34M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2024-12-31
Cash & Cash Equivalents $3.02M $1.91M $338K $725K $1.34M $56K
Cash & Short-Term Investments $3.02M $1.91M $338K $725K $1.34M $56K
Total Current Assets $3.39M $2.78M $501K $1.20M $1.78M $5.28M
Property, Plant & Equipment, Net $11K $12K $12K $13K $198 $941
Total Non-Current Assets $11K $12K $12K $139K $126K $127K
Total Assets $3.40M $2.79M $513K $1.34M $1.91M $5.41M
Short-Term Debt $1.44M $1.44M $1.44M $1.44M $1.44M $19.97M
Total Current Liabilities $3.04M $2.89M $10.30M $2.86M $10.52M $24.75M
Total Non-Current Liabilities $63K $33K $29K $124K $200K $0
Total Liabilities $3.10M $2.92M $10.33M $2.99M $10.72M $24.75M
Total Debt (incl. Leases) $1.44M $1.44M $1.44M $1.44M $1.44M $19.97M
Common Stock $5.6K $4.8K $2.7K $2.7K $2.6K $1.8K
Retained Earnings -$41.40M -$40.00M -$38.87M -$30.70M -$28.88M -$28.67M
Total Stockholders' Equity $301K -$133K -$9.81M -$1.65M -$8.81M -$19.34M
Total Equity $301K -$133K -$9.81M -$1.65M -$8.81M -$19.34M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$10.21M -$3.55M
Depreciation & Amortization $1.8K --
Operating Cash Flow -$9.96M -$1.45M
Capital Expenditure -$13K --
Free Cash Flow -$9.98M --
Investing Cash Flow -$788K -$2.85M
Financing Cash Flow $11.03M $3.92M
Net Change in Cash $281K -$378K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$1.41M -$1.12M -$8.17M -$1.82M $113K -$328K -$230K -$601K
Depreciation & Amortization $468 $518 -- -- -- -- -- --
Operating Cash Flow -$970K -$2.02M -$387K -$601K -$8.82M -$159K -$141K -$206K
Investing Cash Flow -- -- $0 -$13K -$200K -$575K -- --
Financing Cash Flow $2.08M $3.59M $0 $0 $10.32M $713K -- --
Net Change in Cash $1.11M $1.57M -$387K -$614K $1.30M -$21K $9.3K $13K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Assets (ROA) -1990.4% -65.6%
Current Ratio 0.05x 0.21x
Quick Ratio 0.03x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Equity (ROE) -4165.9% -- -- -- -- -- -- --
Return on Assets (ROA) -367.9% -394.3% -1990.4% -168.9% -54.8% -- -65.6% --
Current Ratio 1.12x 0.96x 0.05x 0.42x 0.17x -- 0.21x --
Quick Ratio 0.99x 0.66x 0.03x 0.25x 0.13x -- 0.00x --
Debt to Equity 4.80x -- -- -- -- -- -- --
Net Income Growth (YoY) -1342.2% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001971387) · from March 31, 2024 Data through June 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal